Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 12/20 | 0.45 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.39 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7772827 | 0.93 | PTGS2 (0.46) | PTGS2NPC1MAPTTSHRRAB9A | |
| SCHEMBL7779264 | 0.90 | PTGS2 (0.46) | PTGS2PI4KBPTGS1 | |
| SCHEMBL7779557 | 0.90 | PTGS2 (0.46) | PTGS2PI4KBPTGS1 | |
| SCHEMBL7778127 | 0.88 | PTGS2 (0.52) | PTGS2PI4KBPTGS1 | |
| SCHEMBL7779840 | 0.87 | PTGS2 (0.47) | PTGS2PI4KBPTGS1 | |
| SCHEMBL7778257 | 0.85 | PTGS2 (0.50) | PTGS2PI4KBPTGS1 | |
| SCHEMBL8629873 | 0.85 | PTGS2 (0.41) | PTGS2PI4KBNPC1MAPTTSHR | |
| SCHEMBL7777935 | 0.84 | PTGS2 (0.46) | PTGS2PTGS1GHSR | |
| SCHEMBL7773332 | 0.84 | PTGS2 (0.43) | PTGS2PTGS1GHSR | |
| SCHEMBL8629870 | 0.83 | NPC1 (0.39) | PTGS2PI4KBNPC1MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-1127878-A1 | 3,4 - substituted pyrazoles for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |
| US-5756530-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G. D. SEARLE & CO. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5580985-A | ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION | G. D. SEARLE & CO. (US) | 1996-12-03 | — | — | US | disclosed |
| US-5486534-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1996-01-23 | — | — | US | disclosed |